Lindbrook Capital, LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 272 filers reported holding BLUEBIRD BIO INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$496
-48.7%
163
-44.6%
0.00%
Q2 2023$967
+285.3%
294
+272.2%
0.00%
Q1 2023$251
-95.6%
79
-90.3%
0.00%
-100.0%
Q4 2022$5,661
+183.0%
818
+165.6%
0.00%
Q3 2022$2,000308
+528.6%
0.00%
Q2 2022$0
-100.0%
49
-76.7%
0.00%
Q1 2022$1,0000.0%210
+57.9%
0.00%
Q4 2021$1,000
-66.7%
1330.0%0.00%
-100.0%
Q3 2021$3,000
+50.0%
133
+146.3%
0.00%
Q1 2021$2,000
-50.0%
54
-40.7%
0.00%
-100.0%
Q4 2020$4,000
+300.0%
91
+468.8%
0.00%
Q2 2020$1,000160.00%
Q1 2020$000.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders